EVEROLIMUS-ASSOCIATED ADVERSE EVENTS IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER UPDATED RESULTS FROM BOLERO-2

被引：0
|
作者：
Campbell-Baird, Cynthia [1 ]
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
来源：
ONCOLOGY NURSING FORUM | 2013年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E428 / E428
页数：1
相关论文
共 50 条
  • [1] Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
    Rugo, H. S.
    Pritchard, K. I.
    Gnant, M.
    Noguchi, S.
    Piccart, M.
    Hortobagyi, G.
    Baselga, J.
    Perez, A.
    Geberth, M.
    Csoszi, T.
    Chouinard, E.
    Srimuninnimit, V.
    Puttawibul, P.
    Eakle, J.
    Feng, W.
    Bauly, H.
    El-Hashimy, M.
    Taran, T.
    Burris, H. A., III
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (04) : 808 - 815
  • [2] Everolimus for Postmenopausal Women with Advanced Breast Cancer: Updated Results of the BOLERO-2 Phase Ill Trial.
    Hortobagyi, G. N.
    Piccart, M.
    Rugo, H.
    Burris, H.
    Campone, M.
    Noguchi, S.
    Gnant, M.
    Pritchard, K. I.
    Vittori, L.
    Mukhopadhyay, P.
    Sahmoud, T.
    Lebwohl, D.
    Baselga, J.
    [J]. CANCER RESEARCH, 2011, 71
  • [3] Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
    Piccart-Gebhart, Martine J.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A.
    Rugo, Hope S.
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Melichar, Bohuslav
    Petrakova, Katarina
    Arena, Francis P.
    Xu, Cindy
    Cahana, Ayelet
    Taran, Tanya
    Sahmoud, Tarek
    Lebwohl, David Edward
    Campone, Mario
    Baselga, Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
    Arena, Francis P.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A.
    Rugo, Hope S.
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Latini, Luciano
    Yardley, Denise Aysel
    Melichar, Bohuslav
    Petrakova, Katarina
    Harb, Wael
    Feng, Wentao
    Cahana, Ayelet
    Taran, Tanya
    Campone, Mario
    Baselga, Jose
    Sahmoud, Tarek
    Lebwohl, David Edward
    Piccart-Gebhart, Martine J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [5] Everolimus in postmenopausal hormone-receptor-positive Advanced Breast Cancer The Breast Cancer Trials of Oral Everolimus-2 (BOLERO-2)
    Hadoux, J.
    Delaloge, S.
    [J]. ONCOLOGIE, 2012, 14 (05) : 349 - 350
  • [6] The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
    Beaver, Julia A.
    Park, Ben H.
    [J]. FUTURE ONCOLOGY, 2012, 8 (06) : 651 - 657
  • [7] UPDATED RESULTS OF THE BOLERO-2 PHASE III TRIAL EVALUATING EVEROLIMUS (EVE) FOR POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER (ABC)
    Rugo, H.
    Piccart, M.
    Hortobagyi, G.
    Noguchi, S.
    Gnant, M.
    Campone, M.
    Bauly, H.
    Mukhopadhyay, P.
    Sahmoud, T.
    Baselga, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 46 - 46
  • [8] BOLERO-2: EVEROLIMUS IN COMBINATION WITH EXEMESTANE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER REFRACTORY TO LETROZOLE OR ANASTROZOLE
    Campone, Mario
    Piccart, Martine
    Pritchard, Kathleen I.
    Xu, Cindy
    Gnant, Michael
    Neven, Patrick
    Pistilli, Barbara
    Shtivelband, Mikhail
    Provencher, Louise
    Masuda, Norikazu
    El-Hashimy, Mona
    Vittori, Luc
    Sahmoud, Tarek
    Baselga, Jose
    Hortobagyi, Gabriel N.
    [J]. BREAST, 2011, 20 : S30 - S30
  • [9] Everolimus Added to Exemestane Reduced Bone Markers and Disease Progression in Bone in Postmenopausal Women with Advanced Breast Cancer: Updated Results From the BOLERO-2 Trial
    Gnant, M.
    Hortobagyi, G. N.
    Rugo, H.
    Burris, H. A.
    Noguchi, S.
    Pritchard, K. I.
    Baselga, J.
    Sahmoud, T.
    Bauly, H.
    Piccart, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S2 - S2
  • [10] Everolimus Added to Exemestane Reduced Bone Markers in Postmenopausal Women with Advanced Breast Cancer (ABC): the BOLERO-2 Trial
    Gnant, M.
    Hortobagyi, G. N.
    Rugo, H.
    Burris, H. A.
    Noguchi, S.
    Pritchard, K. I.
    Baselga, J.
    Sahmoud, T.
    Bauly, H.
    Piccart, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S43 - S43
12345